Clinical Rheumatology

, Volume 28, Issue 1, pp 93–94 | Cite as

Miller–Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab

  • Patric Thierry Kurmann
  • Daniel Van LinthoudtEmail author
  • Alexander Kai-Lik So
Case Report


Adalimumab is a frequently prescribed TNFα inhibitor for treatment of rheumatoid arthritis. We report on a patient who probably developed a Miller–Fisher syndrome after the second injection of adalimumab.


Adalimumab Miller–Fisher Rheumatoid arthritis 





  1. 1.
    Fisher M (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophtalmoplegia ataxia and areflexia). N Eng J Med 255:57–65Google Scholar
  2. 2.
    Lo YL (2007) Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 36:915–27CrossRefGoogle Scholar
  3. 3.
    Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862–2869PubMedCrossRefGoogle Scholar
  4. 4.
    Van Oosten BW, Barkhof F, Truyen L et al (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531–1534PubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 2008

Authors and Affiliations

  • Patric Thierry Kurmann
    • 1
    • 2
  • Daniel Van Linthoudt
    • 1
    • 2
    Email author
  • Alexander Kai-Lik So
    • 2
  1. 1.Department of RheumatologyHôpital NeuchâteloisLa Chaux-de-FondsSwitzerland
  2. 2.Department of Rheumatology and RehabilitationCentre Hospitalier Universitaire VaudoisLausanneSwitzerland

Personalised recommendations